Evidence map›Paper›PMID 12554873›Full record

ArticleRNA (New York, N.Y.)2003

Gene silencing in Caenorhabditis elegans by transitive RNA interference.

Matthew N Alder, Shale Dames, Jeffrey Gaudet, Susan E Mango

Open access · bronzeAbstract read
In one paragraph

Article in RNA (New York, N.Y.), 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 120 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The sole essential low molecular weight tropomyosin isoform ofbioRxiv : the preprint server for biology · 2024
    Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. The Whys and Wherefores of Transitivity in Plants.Frontiers in plant science · 2020
    Review
  10. Plant MicroRNAs in Cross-Kingdom Regulation of Gene Expression.International journal of molecular sciences · 2018
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Predicted trans-acting siRNAs in the human brain.International journal of molecular sciences · 2015
    Article
  18. Article
  19. Assays for direct and indirect effects of C. elegans endo-siRNAs.Methods in molecular biology (Clifton, N.J.) · 2014
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Matthew N AlderHuntsman Cancer Institute, University of Utah, Salt Lake City 84112, USA.
Shale Dames
Jeffrey Gaudet
Susan E Mango
University of Utah · US

Funding

UTAH REGIONAL CANCER CENTERP30CA042014 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI CORNELIA M ULRICH · 1986 to 2026
$72.6M
NCI NIH HHS 2P30CA42014NCI NIH HHS P30 CA042014
6 · The paper itself

Abstract

When a cell is exposed to double-stranded RNA (dsRNA), mRNA from the homologous gene is selectively degraded by a process called RNA interference (RNAi). Here, we provide evidence that dsRNA is amplified in Caenorhabditis elegans to ensure a robust RNAi response. Our data suggest a model in which mRNA targeted by RNAi functions as a template for 5' to 3' synthesis of new dsRNA (termed transitive RNAi). Strikingly, the effect is nonautonomous: dsRNA targeted to a gene expressed in one cell type can lead to transitive RNAi-mediated silencing of a second gene expressed in a distinct cell type. These data suggest dsRNA synthesized in vivo can mediate systemic RNAi.

Indexed as

Gene SilencingAnimalsAnimals, Genetically ModifiedBase SequenceCaenorhabditis elegansDNA PrimersGreen Fluorescent ProteinsLuminescent ProteinsMutagenesis, Site-DirectedRNADNA PrimersGreen Fluorescent ProteinsLuminescent ProteinsRNA

Identifiers

PMID12554873
PMCPMC1370367
OpenAlexW2168051144

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.